As a Danish pharma company, Novo Nordisk ( NVO 0.93% ) doesn’t usually get much attention from American healthcare investors. However, it’s about to have its time in the Sun. Thanks to its trio of diabetes and weight-loss medicines, it’s positioned to ramp up its revenue for years, potentially making…Read More
3 Things About Novo Nordisk That Smart Investors Know
